Diagnosis, treatment history, symptoms, demographics, and geography enable protocol-level matching
Patients can be screened and delivered immediately upon site activation.
StudyMax Media is CTM’s proprietary AI-enabled software, built on 30 years of clinical trial enrollment data and hundreds of millions of data points, to make every digital advertising decision smarter. StudyMax™ Media powers industry-leading results for qualified patient access and identification.
Our integrated media platform leverages real-time signals from campaign performance and screening data to drive algorithms to best match audiences with trial protocols.
Coupled with RandIQ™, our predictive enrollment solution, CTM can precisely identify patients across populations, demographics, geographies, and complex cohort stratifications.
randomizations delivered